Ethyl chloroformate → HCID 136347865, compound
Reaction equation
Cl[C:2](OCC)=[O:3].[S:7]1[CH:11]=[CH:10][N:9]=[C:8]1[NH:12][S:13]([C:16]1[CH:34]=[CH:33][C:19]([C:20]([NH:22][NH:23][CH2:24][C:25]2[CH:30]=[CH:29][C:28]([Cl:31])=[C:27]([Cl:32])[CH:26]=2)=[NH:21])=[CH:18][CH:17]=1)(=[O:15])=[O:14]>C1COCC1>[Cl:32][C:27]1[CH:26]=[C:25]([CH:30]=[CH:29][C:28]=1[Cl:31])[CH2:24][N:23]1[C:2](=[O:3])[NH:21][C:20]([C:19]2[CH:18]=[CH:17][C:16]([S:13]([NH:12][C:8]3[S:7][CH:11]=[CH:10][N:9]=3)(=[O:15])=[O:14])=[CH:34][CH:33]=2)=[N:22]1Participants
4
Reactant 2
Product 1
Reagents, catalysts & solvents 1
Conditions
- Temperature
- 95 °C
Procedure
Ethyl chloroformate (0.05 mL) was added to a solution of 4-(thiazol-2-ylsulfamoyl)-N-(3,4-dichlorobenzylamino)-benzamidine (0.044 mmol) and TEA (0.20 mL) in THF (5 mL) at room temperature and the resulting solution was stirred for 2 h. After concentrating in vacuo 1 N NaOH (4 mL) was added and the solution was heated to 95° C. overnight. After the mixture was cooled to room temperature, the solution was acidified with 1 N HCl and freeze dried. The crude material was purification by reverse phase chromatography to yield 4-[1-(3,4-dichloro-benzyl)-5-oxo-4,5-dihydro-1H-[1,2,4]triazol-3-yl]-N-thiazol-2-yl-benzenesulfonamide (0.002 mmol).
Workup
- concentrationAfter concentrating in vacuo 1 N NaOH (4 mL)
- additionwas added
- temperatureAfter the mixture was cooled to room temperature
- customdried
- custompurification by reverse phase chromatography
Sources & evidence
- ORD record
- ord-70281f90a8ed48b5845fdda1b5e9a71e
- Source dataset
- uspto-grants-2009_11
- Patent number
- US07615569B2
Reaction notes
Loading…